Your browser doesn't support javascript.
loading
Formulation Optimization of Budesonide Sustained-release Tablet by Central Composite Design-response Surface Method / 中国药房
China Pharmacy ; (12): 1395-1398, 2017.
Article in Chinese | WPRIM | ID: wpr-515335
ABSTRACT

OBJECTIVE:

To optimize the formulation of Budesonide sustained-release tablet.

METHODS:

Using the cumula-tive releases in 2,4,8 h as investigation indexes,central composite design-response surface method was used to optimize the amount of hydroxypropylcellulose L(HPC-L),amount of soybean phosphatides,and filler(fixed total 200 mg)lactose- micro-crystalline cellulose mass ratio in the formulation of Budesonide sustained-release tablet,and the verification test was conducted. The release behaviors of prepared sustained-release tablet and original preparation in pH 7.2,7.0,6.8 phosphate buffer were com-pared.

RESULTS:

The optimal formulation was as follow as budesonide of 9 mg,HPC-L of 46.49 mg,soybean phosphatides of 9.23 mg,filler lactose-microcrystalline cellulose mass ratio of 12.9;the cumulative releases in 2,4,8 h were 21.9%,50.1%, 99.5%,the relative errors with predicted values (22.0%,50.0%,98.5%) were 0.45%,0.20%,1.02%(n=3),respectively. Compared with cumulative release of original preparation,the f2 was higher than 50.

CONCLUSIONS:

Budesonide sustained-re-lease tablet is successfully prepared,which shows similar release behavior to original preparations.

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: China Pharmacy Year: 2017 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: China Pharmacy Year: 2017 Type: Article